Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

6.535 -0.005 (-0.08%)
Streaming Delayed Price Updated: 3:47 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
30 31 Next >
Psychedelic Stock Gainers And Losers From February 15, 2023
 
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
7 Long-Term Stocks to Buy With Your Tax Refund
Although you might want to spend your tax refund, a better approach is to target compelling long-term stocks to buy. 
Via InvestorPlace
Major Psychedelic Compound-Based Stocks UP 13% YTD
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
 
Via Benzinga
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
7 Tempting Sin Stocks to Buy for Promising Profits
After a rough time in 2022, investors may want to consider sin stocks to buy for a cynical shot at significant upside potential. 
Via InvestorPlace
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
(Part one of a three-part series) 
Via Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. 
Via InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
 
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date. 
Via Talk Markets
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission. 
Via Benzinga
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
 
Via Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
 
Via Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.